Didscussion  by unknown
likelihood of success with minimal morbidity and with
greater salvage of involved grafts.
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DISCUSSION
Dr David K. W. Chew (West Roxbury, Mass). As recently as
one month ago we had a patient who had an infected dialysis graft;
the proximal anastomosis was very densely incorporated, and so
the surgeon left a cuff of the graft and did a subtotal excision. The
patient promptly blew out 2 weeks later from that stump of
prosthetic graft that was left behind. I think it had to do with the
virulence of the infection, which was gram-negative Klebsiella. I
was wondering whether you have any data on the type of bacteria
in your series—whether there is any influence on the safety of the
management that you adopted.
Dr Sean Ryan. That’s a good question. The majority of our
cultures were staph species. We also had some Pseudomonas, Strep-
tococcus viridans, and Enterococcus. In a large portion of our patients,
about 25%, the cultures were negative. There is no way for us to
predict success on the basis of microbiology because the subgroups of
patients were treated in different ways and that dilutes any analysis. I
think that certain bacteria, such as Pseudomonas, based on other
studies we and others have published, are more worrisome.
Dr Peter J. Pappas (Newark, NJ). I want to congratulate you
on tackling a very difficult group of patients. Your data indicates
that you do approximately 200 prosthetic grafts a year. At our
institution we’ve found that the best way to avoid a prosthetic graft
complication is to minimize the use of prosthetic grafts for dialysis
access and maximize the use of autogenous fistulae. I would
therefore like to ask how many autogenous arteriovenous fistulae
were performed at your institution during the same time period.
The second question is, of those patients who required a total
graft excision, did you place another prosthetic graft or did you
look to see if the patient had an autogenous option for access? We
have found that over 50% of our patients who had a prosthetic graft
that failed or had to be removed were candidates for a fistula, if you
investigate their extremity veins, utilizing duplex ultrasonography.
Dr Ryan. We have a strategy at Pennsylvania Hospital where
we perform autogenous primary fistulae whenever possible. We
routinely perform preoperative duplex scan vein mapping of both
upper extremities.
Dr Paul J. Gagne (New York, NY). I congratulate you on your
careful analysis. My question is, you describe using subtotal graft
excision to avoid complications related to total graft excision. In the
patients in whom you performed total graft excision, did you see the
complications that you were trying to avoid with subtotal graft exci-
sion?
And the second part of my question is, a number of the
patients who had partial graft excision went on to total graft
excision. Did they have complications that could have been
avoided if you had done a subtotal excision to begin with?
Dr Ryan. Almost all patients treated by total graft excision did
well and indeed did not suffer the complications we were trying to
avoid by selectively using subtotal graft excision. But remember
that the patients treated by total graft excision often had poorly
incorporated grafts at the anastomosis. Therefore, the dissection
was easier and inadvertent injury to the adjacent veins and nerves
was less likely than if the graft was well incorporated, which were
the situations in which we employed subtotal graft excision. The
six patients who ultimately required total graft excision after failing
partial graft excision also did well.
Dr Dean J. Wickel (San Antonio, Tex). I have a question
about how you and Dr. Calligaro handle patients who are admitted
by the nephrologist for bacteremia, maybe not overtly septic. You
do a CT scan or an ultrasound, you don’t find any obvious fluid
around the graft, and then they order that tagged white cell study
which lights up a little something around your graft. How do you
handle those patients?
Dr Ryan. It really depends on the clinical situation. We agree
that you must aggressively look for other sources of infection. If none
are found and you have a positive white cell scan, the study is very
sensitive for the presence of infection. So I think that you should treat
those aggressively in the absence of any other source of infection.
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